Intracranial delivery of iPSC-derived neural stem cells overexpressing SGSH restored brain enzyme activity and memory while reducing glycosaminoglycan accumulation and neuroinflammation in an immunodeficient MPS IIIA mouse model. These findings support a promising cell-based therapeutic strategy for treating MPS IIIA and related lysosomal storage disorders.